Medication-related osteonecrosis of the jaw (MRONJ) has emerged as a complication of anti-
resorptive medications. Despite its low incidence rate, this problem has gained attention in …

Medication-related osteonecrosis of the jaw (MRONJ), a severe side effect caused by
antiresorptive antiangiogenic medication, particularly bisphosphonates (BPs), has become a …

MRONJ is a serious drug-related side effect that is most common in people using
antiresorptive and/or angiogenic medications. Therapy options for this condition include …

Objective To assess the outcomes of several rodent animal models for studying tooth
extraction-related medication-related osteonecrosis of the jaw (MRONJ). Design After a …

This study compiles the main hypotheses involved in the etiopathogenesis of medication-
related osteonecrosis of the jaw (MRONJ). A narrative review of the literature was …

Medication-related osteonecrosis of the jaw (MRONJ) is a significant side effect of drugs
such as bone modifying agents (BMA) or angiogenesis inhibitors. The incidence has been …

Wound healing is the complex physiological process of restoring the skin's integrity,
structure, and function after damage caused by external conditions. The wound healing …

Medication-related osteonecrosis of the jaw (MRONJ) is a severe disease with unclear
pathogenesis. Adipose tissue-derived mesenchymal stromal cells (MSC (AT) s) serve as a …

Aim This study aimed to assess the effectiveness of photobiomodulation therapy (PBM) in
enhancing bone integration with dental implants. Method PubMed, ScienceDirect, the …

Medication-related osteonecrosis of the jaw (MRONJ) is a drug-related side effect linked but
not limited to antiresorptive and antiangiogenic molecules. It recognizes several triggers in …